Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"

被引：0
|
作者：
Kikuchi, Eiji [1 ]
Hayakawa, Nozomi [1 ]
机构：
[1] St Marianna Univ, Sch Med, Dept Urol, Kawasaki, Kanagawa, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2024年 / 31卷 / 10期
关键词：
RANDOMIZED PHASE-III; METHOTREXATE; VINBLASTINE; DOXORUBICIN;
D O I：
10.1111/iju.15541
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1106 / 1106
页数：1
相关论文
共 50 条
  • [1] Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Urabe, Fumihiko
    Suzuki, Hirotaka
    Iwatani, Kosuke
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1107 - 1107
  • [2] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Hattori, Yuto
    Fujiwara, Tasuku
    Hagimoto, Hiroki
    Kokubun, Hidetoshi
    Murata, Shiori
    Makita, Noriyuki
    Abe, Yohei
    Kubota, Masashi
    Tohi, Yoichiro
    Tsutsumi, Naofumi
    Shibasaki, Noboru
    Inoue, Koji
    Kawakita, Mutsushi
    Yamasaki, Toshinari
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1102 - 1106
  • [3] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).
    Tsironis, George
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Tzanis, Kimon
    Varkarakis, John
    Papatsoris, Athanasios
    Stravodimos, Kostas
    Kostouros, Efthymios
    Fragkoulis, Charalampos
    Choreftaki, Theodosia
    Filippiadis, Dimitrios
    Fontara, Sofia
    Dellis, Athanasios
    Ntai, Sparti
    Zygogianni, Anna
    Ntoumas, Konstantinos
    Constantinides, Constantinos A.
    Korkolopoulou, Penelope
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial
    Anari, Fern
    O'Neill, John
    Choi, Woonyoung
    Chen, David Y. T.
    Haseebuddin, Mohammed
    Kutikov, Alexander
    Dulaimi, Essel
    Alpaugh, R. Katherine
    Devarajan, Karthik
    Greenberg, Richard E.
    Bilusic, Marijo
    Wong, Yu-Ning
    Viterbo, Rosalia
    Hoffman-Censitsc, Jean H.
    Lallas, Costas D.
    Trabulsic, Edouard J.
    Smaldone, Marc
    Geynisman, Daniel M.
    Zibelman, Matthew
    Lin, Jianqing
    Kelly, W. Kevin
    Uzzo, Robert
    McConkey, David
    Plimack, Elizabeth R.
    EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (01): : 54 - 60
  • [5] Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
    Iyer, Gopa
    Balar, Arjun V.
    Milowsky, Matthew I.
    Bochner, Bernard H.
    Dalbagni, Guido
    Donat, S. Machele
    Herr, Harry W.
    Huang, William C.
    Taneja, Samir S.
    Woods, Michael
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat
    Arcila, Maria E.
    Riches, Jamie C.
    Meier, Andreas
    Bourque, Caitlin
    Shady, Maha
    Won, Helen
    Rose, Tracy L.
    Kim, William Y.
    Kania, Brooke E.
    Boyd, Mariel E.
    Cipolla, Catharine K.
    Regazzi, Ashley M.
    Delbeau, Daniela
    McCoy, Asia S.
    Vargas, Hebert Alberto
    Berger, Michael F.
    Solit, David B.
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1949 - +
  • [6] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [7] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 203 (04): : 659 - 660
  • [8] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer
    Voskuilen, Charlotte S.
    van der Heijden, Michiel S.
    van Rhijn, Basw. G.
    EUROPEAN UROLOGY, 2019, 76 (06) : 870 - 871
  • [9] Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
    van de Putte, Elisabeth E. Fransen
    Mertens, Laura S.
    Meijer, Richard P.
    van der Heijden, Michiel S.
    Bex, Axel
    van der Poel, Henk G.
    Kerst, J. Martijn
    Bergman, Andries M.
    Horenblas, Simon
    van Rhijn, Bas W. G.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (02) : 157 - 162
  • [10] Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
    Elisabeth E. Fransen van de Putte
    Laura S. Mertens
    Richard P. Meijer
    Michiel S. van der Heijden
    Axel Bex
    Henk G. van der Poel
    J. Martijn Kerst
    Andries M. Bergman
    Simon Horenblas
    Bas W. G. van Rhijn
    World Journal of Urology, 2016, 34 : 157 - 162
12345